Alexander J. Lazar MD/PhD
Alexander J. Lazar MD/PhD
Professor; Pathology, Genomic Medicine, Dermatology & Transl Molec Pathol, MD Anderson Cancer Ctr
mdanderson.org üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Robbins and Cotran pathologic basis of disease (2010);. Saunders
V Kumar, AK Abbas, JC Aster
ISBN 978-1-4160-3121-5. OCLC 643462931, 0
6621*
AJCC cancer staging manual
MB Amin, SB Edge
springer, 2017
41132017
Robbins basic pathology e-book
V Kumar, AK Abbas, JC Aster
Elsevier Health Sciences, 2017
40742017
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ...
Science 359 (6371), 97-103, 2018
16792018
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
15052015
Pathology of the Skin
JE Calonje, T Brenn, AJ Lazar, PH McKee
Elsevier Health Sciences, 2011
1433*2011
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
12622018
Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ...
CA: a cancer journal for clinicians 67 (6), 472-492, 2017
1043*2017
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
9902018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
8652018
Loss of PTEN promotes resistance to T cell–mediated immunotherapy
W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ...
Cancer discovery 6 (2), 202-216, 2016
7912016
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
7752018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
7682018
NRAS mutation status is an independent prognostic factor in metastatic melanoma
JA Jakob, RL Bassett Jr, CS Ng, JL Curry, RW Joseph, GC Alvarado, ...
Cancer 118 (16), 4014-4023, 2012
6272012
Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade
PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ...
Cancer discovery 6 (8), 827-837, 2016
5142016
Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review
JD Merker, GR Oxnard, C Compton, M Diehn, P Hurley, AJ Lazar, ...
Archives of pathology & laboratory medicine 142 (10), 1242-1253, 2018
4812018
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
VK Goel, AJF Lazar, CL Warneke, MS Redston, FG Haluska
Journal of Investigative Dermatology 126 (1), 154-160, 2006
4572006
The repertoire of mutational signatures in human cancer
LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AWT Ng, Y Wu, A Boot, ...
Nature 578 (7793), 94-101, 2020
4552020
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ...
The Lancet Oncology 18 (11), 1493-1501, 2017
4452017
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
3822018
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20